In vivo screening of subcutaneous tolerability for the development of novel excipients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Toxicologic Pathology"
DOI: 10.1293/tox.2022-0035
Abstract: To develop safe subcutaneous formulations and minimize the risk of local irritation, it is essential to optimize the composition of active pharmaceutical ingredients and excipients. Depending on the physicochemical properties of the active pharmaceutical ingredient,… read more here.
Keywords: development; tolerability; active pharmaceutical; novel excipients ... See more keywords